PAVmed (PAVM) Cash from Operations Growth (1y) (2016 - 2025)
PAVmed (PAVM) Cash from Operations Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -12.60% |
| 10 | PAVmed | 32.44 Mn | 28.66 Mn | -89,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,695.74% |
| Jun 30, 2025 | 89.54% |
| Mar 31, 2025 | 87.94% |
| Dec 31, 2024 | 100.79% |
| Jun 30, 2024 | 8.30% |
| Mar 31, 2024 | 19.88% |
| Dec 31, 2023 | 29.42% |
| Sep 30, 2023 | 42.67% |
| Jun 30, 2023 | 43.65% |
| Mar 31, 2023 | -33.43% |
| Dec 31, 2022 | -0.27% |
| Sep 30, 2022 | -141.22% |
| Jun 30, 2022 | -240.34% |
| Mar 31, 2022 | -33.76% |
| Dec 31, 2021 | -149.36% |
| Sep 30, 2021 | -37.29% |
| Jun 30, 2021 | -19.32% |
| Mar 31, 2021 | -141.84% |
| Dec 31, 2020 | -64.50% |
| Sep 30, 2020 | -102.92% |